So Yeon Park

Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP

Sheehyun Kim, K. Jang, J. Cheon, 2023, Cancer research and treatment.

A Nationwide Study on HER2-low Breast Cancer in South Korea: Its Incidence of 2022 Real World Data and the Importance of Immunohistochemical Staining Protocols.

Ahrong Kim, J. Kim, Y. Bae, 2024, Cancer research and treatment.

Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16).

Min Hwan Kim, S. Im, J. Kim, 2023, European journal of cancer.

Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP

Sheehyun Kim, K. Jang, J. Cheon, 2024, Journal of pathology and translational medicine.

PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma: A Multi-institutional Study.

M. Hirokawa, T. Higashiyama, K. Kakudo, 2024, The American journal of surgical pathology.

Analysis of differential BRAFV600E mutational status in multifocal papillary thyroid carcinoma

G. Choe, H. Jang, D. Park, 2006, Cancer.